ARCII: A Phase II Trial of the HIV Protease Inhibitor Nelfinavir in Combination With Chemoradiation for Locally Advanced Inoperable Pancreatic Cancer

Radiotherapy and Oncology - Netherlands
doi 10.1016/j.radonc.2016.03.021

Related search